§ 13F · FUND PROFILE
Sarissa Capital Management LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 9Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$222.9T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | INVA | INNOVIVA INC | 2.82M | $56.3T | 25.3% | NEW |
| 2 | IRWD | IRONWOOD PHARMACEUTICALS INC | 15.92M | $53.6T | 24.1% | NEW |
| 3 | NBIX | NEUROCRINE BIOSCIENCES INC | 303K | $43.0T | 19.3% | NEW |
| 4 | CYTK | CYTOKINETICS INC | 396K | $25.2T | 11.3% | NEW |
| 5 | AMRN | AMARIN CORP PLC | 1.67M | $23.4T | 10.5% | NEW |
| 6 | LNTH | LANTHEUS HLDGS INC | 181K | $12.1T | 5.4% | NEW |
| 7 | BHVN | BIOHAVEN LTD | 513K | $5.8T | 2.6% | NEW |
| 8 | REGN | REGENERON PHARMACEUTICALS | 4K | $3.2T | 1.5% | NEW |
| 9 | VOR | VOR BIOPHARMA INC | 25K | $332.2B | 0.1% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SARISSA SIGNAL
AC read
Sarissa Capital Management LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed